Emergencies in oncology

Clinical Medicine

Volumn 3, Issue 4, 2003, Pages 306-310

  Thirlwell, Christina ^a   Brock, Cathryn S ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Hypercalcaemia; Neutropenic sepsis; Spinal cord compression; Superior vena cava obstruction; Tumour lysis syndrome

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BICARBONATE; CALCITONIN; CORTICOSTEROID; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; INFUSION FLUID; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; PROSTAGLANDIN E; RASBURICASE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; URIC ACID; ZOLEDRONIC ACID;

ARM SWELLING; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER RADIOTHERAPY; CENTRAL VENOUS CATHETER; CONSTIPATION; COUGHING; DYSPHAGIA; DYSPNEA; EARLY DIAGNOSIS; EMERGENCY; FACE EDEMA; FATIGUE; FEBRILE NEUTROPENIA; GERM CELL TUMOR; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOCALCEMIA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM TUMOR; MENTAL DISEASE; MORTALITY; NAUSEA AND VOMITING; OXYGEN THERAPY; POLYURIA; QUALITY OF LIFE; REVIEW; SEPSIS; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; STENT; SUPERIOR CAVA VEIN OBSTRUCTION; THORAX PAIN; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

EID: 0041928093     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-4-306     Document Type: Review

References (22)

1. Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: a modern management strategy. Review. Clin Oncol (R Coll Radiol) 1997;9:83-9.
2. Tanigawa N, Sawada S, Mishima K, Okuda Y et al. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Comparison with conventional treatment. Acta Radiol 1998;39:669-74.
3. Wilson E, Lyn E, Lynn A, Khan S. Radiological stenting provides effective palliation in malignant central venous obstruction. Clin Oncol (R Coll Radiol) 2002;14:228-32.
4. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990;112:423-8.
5. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 1980;68:486-91.
6. Pui CH. Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Semin Hematol 2001;38(4 Suppl 10):13-21.
7. Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;97:2998-3003.
8. Nicolin G. Emergencies and their management. Review. Eur J Cancer 2002;38:1365-77; discussion 1378-9.
9. Hughes WT, Armstrong D, Bodey GP, Brown AE et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Review. Clin Infect Dis 1997;25:551-73.
10. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
11. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group. Am J Med 1989;86(6 Pt 1):668-72.
12. Ozer H, Armitage JO, Bennett CL, Crawford J et al. American Society of Clinical Oncology. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000;18:3558-85.
13. Coleman RE. Skeletal complications of malignancy. Review. Cancer 1997;80(8 Suppl):1588-94.
14. Lamy O, Jenzer-Closuit A, Burckhardt P. Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. J Intern Med 2001;250:73-9.
15. Bayne MC, Illidge TM. Hypercalcaemia, parathyroid hormone-related protein and malignancy. Review. Clin Oncol (R Coll Radiol) 2001;13:372-7.
16. Payne RB, Carver ME, Morgan DB. Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 1979;32:56-60.
17. Hurtado J, Esbrit P. Treatment of malignant hypercalcaemia. Review. Expert Opin Pharmacother 2002;3:521-7.
18. Cheer SM, Noble S. Zoledronic Acid. Review. Drugs 2001;61:799-805; discussion 806.
19. Loblow DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. Review. J Clin Oncol 1998;16:1613-24.
20. Schiff D, Batchelor T, Wen PY. Neurologic emergencies in cancer patients. Review. Neurol Clin 1998;16:449-83.
21. Loughrey GJ, Collins CD, Todd SM, Brown NM, Johnson RJ. Magnetic resonance imaging in the management of suspected spinal canal disease in patients with known malignancy. Clin Radiol 2000;55:849-55.
22. Helweg-Larsen S, Sorensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 2000;46:1163-9.